Estrella Immunopharma Statistics Share Statistics Estrella Immunopharma has n/a
shares outstanding. The number of shares has increased by -0.58%
in one year.
Shares Outstanding n/a Shares Change (YoY) -0.58% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 10.35M Failed to Deliver (FTD) Shares 6,890 FTD / Avg. Volume 3.88%
Short Selling Information The latest short interest is 162.26K, so 0.45% of the outstanding
shares have been sold short.
Short Interest 162.26K Short % of Shares Out 0.45% Short % of Float 1.61% Short Ratio (days to cover) 8.36
Valuation Ratios The PE ratio is -5.3 and the forward
PE ratio is -1.25.
Estrella Immunopharma's PEG ratio is
-0.23.
PE Ratio -5.3 Forward PE -1.25 PS Ratio 0 Forward PS n/a PB Ratio 9.06 P/FCF Ratio -2.41 PEG Ratio -0.23
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Estrella Immunopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 24.65,
with a Debt / Equity ratio of 0.
Current Ratio 24.65 Quick Ratio 24.65 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 1.63K Effective Tax Rate -0.02%
Stock Price Statistics The stock price has increased by -33.33% in the
last 52 weeks. The beta is 0.34, so Estrella Immunopharma's
price volatility has been higher than the market average.
Beta 0.34 52-Week Price Change -33.33% 50-Day Moving Average 0.89 200-Day Moving Average 1.01 Relative Strength Index (RSI) 49.48 Average Volume (20 Days) 177,564
Income Statement
Revenue n/a Gross Profit n/a Operating Income -7.31M Net Income -7.31M EBITDA -7.31M EBIT -7.31M Earnings Per Share (EPS) -0.21
Full Income Statement Balance Sheet The company has 4.17M in cash and 0 in
debt, giving a net cash position of 4.17M.
Cash & Cash Equivalents 4.17M Total Debt n/a Net Cash n/a Retained Earnings -19.5M Total Assets 2.98M Working Capital -7.59M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -16.07M
and capital expenditures -4, giving a free cash flow of -16.07M.
Operating Cash Flow -16.07M Capital Expenditures -4 Free Cash Flow -16.07M FCF Per Share -0.46
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
